Afiliat la F.C.E. ARENSIA Exploratory Medicine

2022 - 1

Safety, pharmacokinetics, and antiviral activity of the capsid inhibitor AB-506 from Phase 1 studies in healthy subjects and those with hepatitis B

Yuen Man-Fung , Berliba Elina , Sukeepaisarnjaroen Wattana , Ahn Sang Hoon , Tanwandee Tawesak , Lim Young-Suk , Kim Yoon Jun , Poovorawan Kittiyod , Tangkijvanich Pisit , Schwabe Christian , Eley Timothy , Brown Joanne , Noi Autori , Gane Edward John

Hepatology Communications

Vol. 6, / 2022 / ISSN 2471-254X

Disponibil online 12 September, 2023

-----------------------------------------------------------------------------------------------------------------------------------

2020 - 1

A combination of AT-527, a pan-genotypic guanosine nucleotide prodrug, and daclatasvir was well-tolerated and effective in HCV-infected subjects

Mungur Ounisha , Berliba Elina , Bourgeois Stefan , Cardona Marine , Jucov Alina , Good Steven Spencer , Moussa Adel , Pietropaolo Keith , Zhou Xiaojian , Brown Nathaniel , Sommadossi Jean Pierre

Journal of Hepatology

Vol. 73, Supl. nr. 1 / 2020 / ISSN 0168-8278 / ISSNe 1600-0641

Disponibil online 11 April, 2024

-----------------------------------------------------------------------------------------------------------------------------------

2013 - 1

ALS-2200, a novel once-daily nucleotide HCV polymerase inhibitor, demonstrates potent antiviral activity in treatmentnaıve GT1 chronic hepatitis C patients

Marcellin Patrick , Popa Sergiu , Berliba Elina , Boyer Nathalie , Streinu-Cercel Anca , Tong Myron , Kauffman Robert , Koziel Margaret , Chanda Sushmita , Zhang Qingling , Westland Christopher E. , Beigelman Leonid N. , Blatt Lawrence Mitchell , Fry John

Hepatology International

Nr. S1(7) / 2013 / ISSN 1936-0533 / ISSNe 1936-0541

Disponibil online 17 December, 2021

-----------------------------------------------------------------------------------------------------------------------------------

10203040501005001000